Overview

A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. The aim of this clinical trial is to investigate the effect of NN1250 (insulin degludec) in Japanese subjects with type 1 diabetes.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin, Globin Zinc
Insulin, Long-Acting